This summary of findings paper on GHTC's nonprofit product development organizations (NPPDs) series provides an overview of the key challenges, lessons, and potential solutions identified by NPPDs in their efforts to advance the development of new vaccines, drugs, diagnostics, microbicides, and other health products for low- and middle-income countries.
Each year, the GHTC releases a policy report that includes recommendations for how US policymakers can continue to advance innovation and save lives around the world. A print summary version (2.7 MB PDF) of the report is also available.
The Global Health Innovative Technology Fund (GHIT Fund) has awarded seven new grants totaling US$15.3 million to tackle malaria, Chagas disease, and dengue fever. The investments aim to speed up the development of promising drugs and vaccines to battle these three insect-borne diseases.